UK markets closed

Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.81-0.30 (-4.22%)
At close: 04:00PM EDT
6.91 +0.10 (+1.47%)
After hours: 06:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-91,055
-90,210
-60,345
-50,158
-40,053
Depreciation & amortisation
895
881
1,032
512
394
Deferred income taxes
143
141
392
219
693
Stock-based compensation
25,626
25,536
10,768
8,146
1,691
Change in working capital
-6,832
1,291
-1,037
-1,425
5,060
Accounts payable
-989
1,149
-722
1,727
-1,146
Other working capital
-75,887
-67,442
-49,384
-42,167
-30,393
Other non-cash items
-
-
-
-
2,887
Net cash provided by operating activities
-75,806
-67,390
-49,109
-41,827
-29,809
Cash flows from investing activities
Investments in property, plant and equipment
-
-52
-275
-340
-584
Purchases of investments
-302,513
-275,781
-139,731
-166,297
-715
Sales/maturities of investments
244,673
237,846
117,734
46,941
7,992
Net cash used for investing activities
-57,921
-37,987
-22,272
-119,696
6,693
Cash flows from financing activities
Debt repayment
-
-
0
-12,880
0
Common stock issued
13,687
41,611
167,253
136,362
0
Other financing activities
-
-344
-401
9,997
-858
Net cash used provided by (used for) financing activities
14,371
41,951
167,095
134,393
85,515
Net change in cash
-119,255
-63,309
95,536
-27,155
62,479
Cash at beginning of period
184,354
143,235
47,699
74,854
12,375
Cash at end of period
64,998
79,926
143,235
47,699
74,854
Free cash flow
Operating cash flow
-75,806
-67,390
-49,109
-41,827
-29,809
Capital expenditure
-
-52
-275
-340
-584
Free cash flow
-75,887
-67,442
-49,384
-42,167
-30,393